Agenus Inc
AGEN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001098972
No open-market purchases or sales by Agenus Inc insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $43.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Agenus Inc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 85
- −13 vs. Q3 2024
- Shares held
- 8.44M
- +21.9K (+0.3%) vs. Q3 2024
- Total value
- $23.1M
- −$22.6M (−49.5%) vs. Q3 2024
- New holders
- 17
- 28 more added
- Sold out
- 30
- 18 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 103 | $43.6M |
| Q1 2026 | 88 | $30.8M |
| Q4 2025 | 96 | $31.8M |
| Q3 2025 | 87 | $33.9M |
| Q2 2025 | 92 | $40.7M |
| Q1 2025 | 88 | $13.3M |
| Q4 2024 | 85 | $23.1M |
| Q3 2024 | 98 | $45.8M |
| Q2 2024 | 89 | $148.6M |
| Q1 2024 | 127 | $119.0M |
| Q4 2023 | 173 | $189.1M |
| Q3 2023 | 164 | $246.9M |
| Q2 2023 | 160 | $341.1M |
| Q1 2023 | 161 | $315.7M |
| Q4 2022 | 160 | $423.7M |
| Q3 2022 | 165 | $336.3M |
| Q2 2022 | 150 | $284.6M |
| Q1 2022 | 172 | $333.7M |
| Q4 2021 | 175 | $431.0M |
| Q3 2021 | 167 | $631.4M |
| Q2 2021 | 145 | $634.7M |
| Q1 2021 | 141 | $316.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Agenus Inc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caption Management, LLC | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| EP Wealth Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −70,616−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −7,262−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −6,323−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −5,759−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −143−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Community Bank, N.A. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Jaffetilchin Investment Partners, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |